Imiquimod: modes of action.
Bilu
Donna
D
Department of Dermatology, Johns Hopkins University, 601 N. Caroline Street, Suite 6072, Baltimore, MD, USA.
Sauder
D N
DN
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000634:Aminoquinolines / Q000627:therapeutic use*; D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology; D006801:Humans; D000077271:Imiquimod; D007156:Immunologic Memory; D008562:Membrane Glycoproteins / Q000187:drug effects; D051379:Mice; D011956:Receptors, Cell Surface / Q000187:drug effects; D017193:Skin Diseases, Viral / Q000188:drug therapy* / Q000276:immunology; D013268:Stimulation, Chemical; D013601:T-Lymphocytes / Q000276:immunology; D051193:Toll-Like Receptors; D014765:Viral Vaccines / Q000600:supply & distribution
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D008562:Membrane Glycoproteins; D011956:Receptors, Cell Surface; D051193:Toll-Like Receptors; D014765:Viral Vaccines; D000077271:Imiquimod